In this volume supportive care in cancer therapy a part of the cancer drug discovery and development series the contributors provide an up to date concise review of specific consequences of cancer and its treatment. In 2009 nci consolidated its anticancer drug discovery and development activities and resources into a single program called the nci experimental therapeutics next program the mission of next is to advance clinical practice and bring improved therapies to cancer patients by supporting the most promising new drug and biologic agent discovery and development projects. Post clinical research which takes place after the drug is approved drug discovery and initial testing the discovery of new cancer drugs can happen in different ways accidental discovery in the early 1940s an explosion exposed sailors to poisonous mustard gas doctors found that these sailors had low white blood cell counts. The division of cancer prevention dcp conducts and supports research to determine a persons risk of cancer and to find ways to reduce the risk prevent cancer preclinical drug development program prevent program to assess the rigor and reproducibility of exosome derived analytes for cancer detection other supportive care issues . Infographic highlight nci supports the best ideas in preclinical cancer prevention agent development using contract resources view the infographic prevent is a peer reviewed program designed to support development of the best ideas in cancer prevention using nci contract resources the program is a pipeline that focuses on unmet needs in prevention that are not adequately addressed by the
How it works:
1. Register Trial Account.
2. Download The Books as you like ( Personal use )